| Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma A Katagiri, K Nakayama, MT Rahman, M Rahman, H Katagiri, ... Modern Pathology 25 (2), 282-288, 2012 | 225 | 2012 |
| IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases MT Rahman, C Ghosh, M Hossain, D Linfield, F Rezaee, D Janigro, ... Biochemical and biophysical research communications 507 (1-4), 274-279, 2018 | 140 | 2018 |
| EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target K Iida, K Nakayama, MT Rahman, M Rahman, M Ishikawa, A Katagiri, ... British journal of cancer 105 (3), 420-427, 2011 | 100 | 2011 |
| Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma M Rahman, K Nakayama, MT Rahman, N Nakayama, M Ishikawa, ... Human pathology 43 (12), 2197-2206, 2012 | 73 | 2012 |
| Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer MT Rahman, K Nakayama, M Rahman, H Katagiri, A Katagiri, T Ishibashi, ... American journal of clinical pathology 138 (4), 535-544, 2012 | 67 | 2012 |
| Prognostic and therapeutic impact of the chromosome 20q13. 2 ZNF217 locus amplification in ovarian clear cell carcinoma MT Rahman, K Nakayama, M Rahman, N Nakayama, M Ishikawa, ... Cancer 118 (11), 2846-2857, 2012 | 65 | 2012 |
| Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes S Yeasmin, K Nakayama, MT Rahman, M Rahman, M Ishikawa, K Iida, ... Gynecologic oncology 117 (3), 409-416, 2010 | 62 | 2010 |
| CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas K Nakayama, MT Rahman, M Rahman, K Nakamura, M Ishikawa, ... International journal of oncology 48 (2), 506-516, 2016 | 58 | 2016 |
| PPP2R1A Mutation Is a Rare Event in Ovarian Carcinoma Across Histological Subtypes M Rahman, K Nakayama, MT Rahman, N Nakayama, H Katagiri, ... Anticancer research 33 (1), 113-118, 2013 | 51 | 2013 |
| Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas S Yeasmin, K Nakayama, MT Rahman, M Rahman, M Ishikawa, A Katagiri, ... Human pathology 43 (4), 506-519, 2012 | 49 | 2012 |
| Biological role and prognostic significance of NAC1 in ovarian cancer K Nakayama, MT Rahman, M Rahman, S Yeasmin, M Ishikawa, A Katagiri, ... Gynecologic oncology 119 (3), 469-478, 2010 | 45 | 2010 |
| Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer MT Rahman, K Nakayama, M Ishikawa, M Rahman, H Katagiri, A Katagiri, ... Oncology 84 (3), 166-173, 2013 | 40 | 2013 |
| Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer M Rahman, K Nakayama, MT Rahman, H Katagiri, A Katagiri, T Ishibashi, ... Human pathology 44 (1), 103-109, 2013 | 39 | 2013 |
| Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas MT Rahman, K Nakayama, M Rahman, H Katagiri, A Katagiri, T Ishibashi, ... British journal of cancer 107 (2), 300-307, 2012 | 39 | 2012 |
| Effects of thrombospondin-4 on pro-inflammatory phenotype differentiation and apoptosis in macrophages MT Rahman, S Muppala, J Wu, I Krukovets, D Solovjev, D Verbovetskiy, ... Cell Death & Disease 11 (1), 53, 2020 | 38 | 2020 |
| Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition S Yeasmin, K Nakayama, MT Rahman, M Rahman, M Ishikawa, A Katagiri, ... International Journal of Cancer 128 (1), 94-104, 2011 | 35 | 2011 |
| Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix A Katagiri, K Nakayama, MT Rahman, M Rahman, H Katagiri, M Ishikawa, ... International Journal of Gynecologic Cancer 22 (2), 208-212, 2012 | 32 | 2012 |
| KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas MT Rahman, K Nakayama, M Rahman, H Katagiri, A Katagiri, T Ishibashi, ... International journal of molecular sciences 14 (7), 13748-13762, 2013 | 30 | 2013 |
| Gene Amplification of ZNF217 Located at chr20q13. 2 is Associated with Lymph Node Metastasis in Ovarian Clear Cell Carcinoma MT Rahman, K Nakayama, M Rahman, H Katagiri, A Katagiri, T Ishibashi, ... Anticancer research 32 (8), 3091-3095, 2012 | 28 | 2012 |
| Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis S Vijayaraghavalu, Y Gao, MT Rahman, R Rozic, N Sharifi, RJ Midura, ... Biomaterials 227, 119558, 2020 | 27 | 2020 |
Vinod Labhasetwar, Ph.D.Professor, Biomedical Engineering, Lerner Research Institute, Cleveland Clinic在 ccf.org 的电子邮件经过验证
